“The [DS]/MSM are now red pilling America, people are seeing the truth, the boomerang is coming back to hit the [DS]. All the treasons criminals are in one place. The public must believe and accept, the MSM will try to fight back. The plan is in motion, the countdown has started, the patriots are preparing to make their move.”
While many have hitched their hope for a return to normalcy and a sense of safety to the rollout of COVID-19 vaccines, early reports are cause for concern. It didn’t take long before reports of serious side effects started emerging in popular media and on social media networks. Examples include:
Persistent malaise1,2 and extreme exhaustion3
Multisystem inflammatory syndrome7
Chronic seizures and convulsions8,9,10
Paralysis,11 including cases of Bell’s Palsy12
Sudden death within hours or days13,14,15
High Rate of Side Effects
According to the U.S. Centers for Disease Control and Prevention,16 by December 18, 2020, 112,807 Americans had received their first dose of COVID-19 vaccine. Of those, 3,150 suffered one or more “health impact events,” defined as being “unable to perform normal daily activities, unable to work, required care from doctor or health care professional.”
That gives us a side effect rate of 2.79%. Extrapolated to the total U.S. population of 328.2 million, we may then expect 9,156,780 Americans to be injured by the vaccine if every single man, woman and child is vaccinated.
When I checked the Vaccine Adverse Event Reporting System (VAERS) January 13, 2021, the total number of reported adverse events for the COVID-19 vaccine (any manufacturer) stood at 3,920.
In a January 4, 2021, article17 in The BMJ Opinion, Peter Doshi, associate editor of The BMJ, again raised questions about the stated efficacy rate of Pfizer’s and Moderna’s COVID-19 vaccines, saying “we need more details and the raw data.”
Previously, in a November 26, 2020, BMJ article,18 Doshi had pointed out that while Pfizer claims its vaccine is 95% effective, this is the relative risk reduction. The absolute risk reduction is actually less than 1%. This is the typical Big Pharma trick: confusing absolute and relative risks. They played this card in spades with the statin drugs and made tens if not hundreds of billions in profits. He also stressed that severe side effects appear commonplace:
“Moderna’s press release states that 9% experienced grade 3 myalgia and 10% grade 3 fatigue; Pfizer’s statement reported 3.8% experienced grade 3 fatigue and 2% grade 3 headache. Grade 3 adverse events are considered severe, defined as preventing daily activity. Mild and moderate severity reactions are bound to be far more common.”
In his January 4 article,19 Doshi delves into recently released summary data20 given to the Food and Drug Administration. “While some of the additional details are reassuring, some are not,” he says. In fact, his article outlines yet additional concerns “about the trustworthiness and meaningfulness of the reported efficacy results” of these two vaccines based on that data.
Relative Risk Reduction May Be Far Below Required Threshold
For starters, Doshi points out that Pfizer did not consistently confirm whether test subjects who showed symptoms of COVID-19 were actually PCR positive. Instead, a large portion of them were simply marked as “suspected COVID-19.”
In all, there were 3,410 cases of “suspected but not confirmed” COVID-19 in the total study population (vaccine group and controls), 1,594 of which occurred in the vaccine group. Only eight cases in the vaccine group were actually confirmed with PCR testing. The problem with this is that the 95% effectiveness rating is based on PCR confirmed cases only. Doshi writes:21
“With 20 times more suspected than confirmed cases, this category of disease cannot be ignored simply because there was no positive PCR test result. Indeed, this makes it all the more urgent to understand.
A rough estimate of vaccine efficacy against developing COVID-19 symptoms, with or without a positive PCR test result, would be a relative risk reduction of 19% — far below the 50% effectiveness threshold for authorization set by regulators.
Even after removing cases occurring within 7 days of vaccination (409 on Pfizer’s vaccine vs. 287 on placebo), which should include the majority of symptoms due to short-term vaccine reactogenicity, vaccine efficacy remains low: 29%.”
It’s worth noting that, for some reason, far more people in the vaccine group ended up with COVID-19 symptoms within that first week than did those in the placebo group.
Doshi goes on to state that if suspected cases occurred in people who had false negative PCR test results, then the vaccine’s efficacy would be lowered even further. He also stresses that “average clinical severity” is not really all that important. What really matters is the “incidence of severe disease that affects hospital admissions.”
Unfortunately, and this is really shocking, the trials were not designed to assess whether the vaccines prevent transmission of the infection. Since they don’t, “an analysis of severe disease irrespective of etiologic agent — namely, rates of hospitalizations, ICU cases, and deaths amongst trial participants — seems warranted, and is the only way to assess the vaccines’ real ability to take the edge off the pandemic,” Doshi writes.
Why Were so Many in Vaccine Group Excluded?
Another concern brought forth in Doshi’s article is the exclusion of 371 participants from Pfizer’s efficacy analysis due to “important protocol deviations on or prior to seven days after Dose 2.” Of those, 311 were from the vaccine group while only 60 were in the placebo group.
This marked imbalance is cause for concern. Why were five times as many in the vaccine group excluded from the efficacy analysis than in the placebo group? And what exactly were these “protocol deviations” that caused them to be excluded? This is called stacking the deck so the results can be manipulated in the desired direction to “prove” effectiveness, when it is merely a statistical manipulation.
Doshi is also concerned about the confounding role of pain and fever medications. These kinds of medications can mask symptoms, resulting in mild cases of COVID-19 going undetected, especially since all participants were not tested. They can also mask side effects of the vaccine.
The data suggest that in the Pfizer trial, pain and fever medication was taken three to four times more often by vaccine recipients than among those in the placebo group though, and according to Doshi:
“Their use was presumably concentrated in the first week after vaccine use, taken to relieve post-injection local and systemic adverse events. But the cumulative incidence curves suggest a fairly constant rate of confirmed COVID-19 cases over time, with symptom onset dates extending well beyond a week after dosing.
That said, the higher rate of medication use in the vaccine arm provides further reason to worry about unofficial unblinding. Given the vaccines’ reactogenicity, it’s hard to imagine participants and investigators could not make educated guesses about which group they were in. The primary endpoint in the trials is relatively subjective making unblinding an important concern.”
He also questions Pfizer’s use of an “adjudication committee” to count COVID-19 cases. “Were they blinded to antibody data and information on patients’ symptoms in the first week after vaccination?” he asks.
“What criteria did they employ, and why, with a primary event consisting of a patient-reported outcome (COVID-19 symptoms) and PCR test result, was such a committee even necessary?” Furthermore, the committee consisted not of licensed doctors but of Pfizer staff members, which makes one wonder whether they had the appropriate qualifications to determine whether someone might have COVID-19 or not.
Does Vaccine Work in Those Who Already Had COVID-19?
Lastly, it’s important to ascertain how the vaccine works for those who have already had COVID-19, seeing how the vaccine is recommended for everyone, regardless of whether or not you’ve already recovered from the infection. Here, the data reveal something rather odd. Doshi writes:22
“Individuals with a known history of SARS-CoV-2 infection … were excluded from Moderna’s and Pfizer’s trials. But still 1,125 (3.0%) and 675 (2.2%) of participants in Pfizer’s and Moderna’s trials, respectively, were deemed to be positive for SARS-CoV-2 at baseline …
By my count, Pfizer apparently reported 8 cases of confirmed, symptomatic COVID-19 in people positive for SARS-CoV-2 at baseline (1 in the vaccine group, 7 in the placebo group …) and Moderna, 1 case (placebo group …)
But with only around four to 31 reinfections documented globally, how, in trials of tens of thousands, with median follow-up of two months, could there be nine confirmed covid-19 cases among those with SARS-CoV-2 infection at baseline?
Is this representative of meaningful vaccine efficacy, as CDC seems to have endorsed? Or could it be something else, like prevention of COVID-19 symptoms, possibly by the vaccine or by the use of medicines which suppress symptoms, and nothing to do with reinfection?”
Vaccine Rollout Coincides With Outbreak
Whether or not the vaccine is helpful or harmful in people who either had COVID-19 before, or are currently positive for SARS-CoV-2 or ill with COVID-19 symptoms, is an important question now that these vaccines are being rolled out.
Case in point: In Auburn, New York, a COVID-19 outbreak began December 21, 2020, in a Cayuga County nursing home.23,24 Before this outbreak, no one in the nursing home had died from COVID-19.
The next day, December 22, they started vaccinating residents and staff. The first death was reported December 29, 2020. Between December 22, 2020, and January 9, 2021, 193 residents (80%) received the vaccine, as did 113 staff members.
As of January 9, 2021, 137 residents had been infected and 24 had died. Forty-seven staff members had also tested positive for SARS-CoV-2 and one was on life-support. Considering we’re seeing cases in which healthy young and middle-aged individuals die within days of receiving the vaccine, it’s not inconceivable that the vaccine might have something to do with this dramatic rise in deaths among the elderly. In fact, I’d expect it.
You can rest assured that the public health authorities and media will never report on these observations. Anything that conflicts with vaccine safety and effectiveness will be intentionally and universally buried. This is precisely their modus operandi of the past three decades. If anything, the suppression of the facts will only be amplified.
Vaccine May Trigger More Serious Illness
One of the original concerns with COVID-19 vaccines was the possibility of paradoxical immune enhancement or antibody-dependent enhancement. As discussed in my May 2020 interview with Robert Kennedy Jr., embedded above for your convenience, this is why previous coronavirus vaccines have failed.
As noted in the study,25 “Informed Consent Disclosure to Vaccine Trial Subjects of Risk of COVID-19 Vaccine Worsening Clinical Disease,” published in the International Journal of Clinical Practice October 28, 2020, “COVID?19 vaccines designed to elicit neutralizing antibodies may sensitize vaccine recipients to more severe disease than if they were not vaccinated.”
“Vaccines for SARS, MERS and RSV have never been approved, and the data generated in the development and testing of these vaccines suggest a serious mechanistic concern:
Vaccines designed empirically using the traditional approach (consisting of the unmodified or minimally modified coronavirus viral spike to elicit neutralizing antibodies), be they composed of protein, viral vector, DNA or RNA and irrespective of delivery method, may worsen COVID?19 disease via antibody?dependent enhancement (ADE),” the paper states.26
“The specific and significant COVID?19 risk of ADE should have been and should be prominently and independently disclosed to research subjects currently in vaccine trials, as well as those being recruited for the trials and future patients after vaccine approval, in order to meet the medical ethics standard of patient comprehension for informed consent.”
The 2003 review paper, “Antibody-Dependent Enhancement of Virus Infection and Disease,” explains it this way:27
“In general, virus-specific antibodies are considered antiviral and play an important role in the control of virus infections in a number of ways. However, in some instances, the presence of specific antibodies can be beneficial to the virus. This activity is known as antibody-dependent enhancement (ADE) of virus infection.
The ADE of virus infection is a phenomenon in which virus-specific antibodies enhance the entry of virus, and in some cases the replication of virus, into monocytes/macrophages and granulocytic cells through interaction with Fc and/or complement receptors.
This phenomenon has been reported in vitro and in vivo for viruses representing numerous families and genera of public health and veterinary importance. These viruses share some common features such as preferential replication in macrophages, ability to establish persistence, and antigenic diversity. For some viruses, ADE of infection has become a great concern to disease control by vaccination.”
Pathogenic Priming — Another Significant Risk
But that’s not all. SARS-CoV-2 vaccines may also trigger autoimmune reactions through a process called “pathogenic priming.” According to a 2020 paper28 in the Journal of Translational Autoimmunity, “Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity,” noting that the same may apply post-vaccination.
As explained in this paper, all but one of SARS-CoV-2 immunogenic epitopes are similar to human proteins. Epitopes29 are sites on the virus that allow antibodies or cell receptors in your immune system to recognize it.
This is why epitopes are also referred to as “antigenic determinants,” as they are the part that is recognized by an antibody, B-cell receptor or T-cell receptor. Most antigens — substances that bind specifically to an antibody or a T-cell receptor — have several different epitopes, which allow it to be recognized by several different antibodies.
According to the author, some epitopes can cause “autoimmunological pathogenic priming due to prior infection or following exposure to SARS-CoV-2 … following vaccination.”
In other words, if you’ve had the infection once, and get reinfected (either by SARS-CoV-2 or a sufficiently similar coronavirus), the second bout has a great potential to be more severe than the first. Similarly, if you get vaccinated and are then infected with SARS-CoV-2, your infection may be more severe than had you not been vaccinated.
For this reason, “these epitopes should be excluded from vaccines under development to minimize autoimmunity due to risk of pathogenic priming,” the paper warns. The abstract lays out the basics of the pathogenic priming process.30
Autoimmune Reactions Involved in Many Lethal COVID-19 Cases
According to the author, autopsies suggest many lethal COVID-19 cases were likely due to autoimmune reactions. A combination of genetic and environmental factors will influence a person’s individual risk for this, just as genetic and environmental factors influence your risk of getting sick from the virus in the first place.
“Among coronaviruses, the spike surface glycoprotein is known to play a role in neuroimmunopathology. However, the SARS-CoV-2 virus has numerous other proteins and polyproteins, each which may serve as an antigen source during infection leading to autoimmunity,” the author notes.
“Remarkably, over 1/3 (11/27) of the immunogenic proteins in SARS-CoV-2 have potentially problematic homology to proteins that are key to the human adaptive immune system … Mapping of the overall gene list … revealed that many functions of the human adaptive immune system might be impacted via autoimmunity against these proteins and their interactors …
These results could explain in part the high rates of serious illness associated with SARS-CoV-2. They could also explain the lengthy asymptomatic period prior to presentation of symptoms characteristic of COVID-19. SARS-CoV-2 could impair the immune response, at first, and then, over time, the immune system could begin to mount an attack on the myriad of proteins …
Unintended consequences of pathogenesis from vaccines are not new, nor are they unexpected. They are unanticipated only if those who develop them do not include available knowledge in their formulation plan.
For example, the H1N1 influenza vaccine used in Europe led to narcolepsy in some patients, resulting from homology between the human hypocretin (aka, orexin) receptor 2 molecule and proteins present in the vaccine. This was established via the detection of cross-reactive antibodies in the serum of patients who develop narcolepsy following H1N1 vaccination in Europe.
The fact that pathogenic priming may be occurring involving autoimmunity against multiple proteins following CoV vaccination is consistent with other observations observed during autoimmunity, including the release of proinflammatory cytokines and cytokine storm.”
Do a Risk-Benefit Analysis Before Making Up Your Mind
Additional studies explaining how coronavirus vaccines can cause problems can be found in “How COVID-19 Vaccine Can Destroy Your Immune System.” In closing, I would urge you to review the science before making up your mind about the vaccine. That includes mortality data for COVID-19, which is actually surprisingly low.
The lethality of COVID-19 is actually lower than the flu for those under the age of 60.31 If you’re under the age of 40, your risk of dying from COVID-19 is just 0.01%, meaning you have a 99.99% chance of surviving the infection. And you could improve that to 99.999% if you’re metabolically flexible, insulin sensitive, and vitamin D replete.
So, really, what are we protecting against with a COVID-19 vaccine? As mentioned, the vaccines aren’t even designed to prevent infection, only reduce the severity of symptoms. Meanwhile, they could potentially make you sicker once you’re exposed to the virus, and/or cause persistent serious side effects such as those listed at the beginning of this article.
While I won’t tell anyone to do, I would urge you to take the time to CAREFULLY review the science and weigh the potential risks and benefits based on your individual situation before you make a decision that you may regret for the rest of your life, which can actually be shortened with this vaccine.
Tech giants with deep ties to the U.S. national security state — Microsoft, Oracle and the MITRE Corporation — announced that they had partnered with several health care companies to create the Vaccination Credential Initiative (VCI) to advance the implementation of digital COVID-19 vaccination records.
According to a Reuters report, the VCI “aims to help people get encrypted digital copies of their immunization records stored in a digital wallet of their choice” because the “current system [of vaccination records] does not readily support convenient access and sharing of verifiable vaccination records.”1
The initiative, on its website,2 notes that the VCI is a public-private partnership “committed to empowering individuals with digital vaccination records” so that participants can “protect and improve their health” and “demonstrate their health status to safely return to travel, work, school and life while protecting their data privacy.”
The initiative is essentially built on a common framework of digital vaccination “wallets” called SMART Health Cards that are meant to “work across organizational and jurisdictional boundaries”3 as part of a new global vaccination-record infrastructure.
The host of the VCI website and one of the initiative’s key backers is the Commons Project Foundation. That foundation, in partnership with the World Economic Forum (WEF), runs the Common Trust Network,4 which has three goals that are analogous to those of VCI.
As listed on the WEF website, the network’s goals are (1) to empower individuals by providing digital access to their health information; (2) to make it easier for individuals to understand and comply with each destination’s requirements; and (3) to help ensure that only verifiable lab results and vaccination records from trusted sources are presented for the purposes of cross-border travel and commerce.
To advance these goals, the Common Trust Network is powered by “a global registry of trusted laboratory and vaccination data sources” as well as “standard formats for lab results and vaccination records and standard tools to make those results and records digitally accessible.”
Another, and related, Commons Project Foundation and WEF partnership is CommonPass. CommonPass, which is also supported by the Rockefeller Foundation, is both a framework and an app that “will allow individuals to access their lab results and vaccination records, and consent to have that information used to validate their COVID status without revealing any other underlying personal health information.”
Current members5 of CommonPass, including JetBlue, Lufthansa, Swiss International Airlines, United Airlines and Virgin Atlantic, are also members of the Common Trust Network. This overlap between the Commons Project Foundation/WEF partnerships and the VCI illustrates that the WEF itself is involved with the VCI, albeit indirectly through their partners at the Commons Project Foundation.
The Commons Project Foundation itself is worth exploring, as its cofounders, Paul Meyer and Bradley Perkins, have long-standing ties to the RAND Corporation, the U.S. Centers for Disease Control and Prevention and the International Rescue Committee, as noted by MintPress News.6
The IRC, currently run by Tony Blair protégé David Milliband, is developing7 a biometric ID and vaccination-record system for refugees in Myanmar in cooperation with the ID2020 Alliance, which is partnered with CommonPass backer, the Rockefeller Foundation. In addition, the ID2020 Alliance funds the Commons Project Foundation and is also backed by Microsoft, one of the key companies behind the VCI.
Wearable IDs for Your Health and Your Wallet
Overlap between digital vaccination records, promoted via initiatives such as CommonPass and VCI, and the push for a new global digital-identity system is no coincidence. Indeed, the developer of VCI’s SMART Health Cards framework at Microsoft Health, Josh C. Mandel, noted in his overview presentation8 on that framework that digital identity is integral to the digital vaccination-record effort.
SMART Health Cards, as of now, are expected to include a person’s complete name, gender, birth date, mobile phone number and email address in addition to vaccination information, though it is possible and likely that more personal information will be required as the initiative advances, given that VCI states that these identifiers are merely a starting point.9
While advertised as digital vaccination records, SMART Health Cards are clearly intended to be used for much more. For instance, public information on the framework notes that SMART Health Cards are “building blocks that can be used across health care,” including managing a complete immunization record that goes far beyond COVID-19 vaccines, sharing data with public health agencies and communication with health care providers.
Yet, this framework will not be limited to health care information, as Mandel has said. In his presentation, he notes the application of SMART Health Cards could soon be used as IDs for commercial activity, such as renting a car. The VCI framework’s use of the term “digital wallet” to refer to its digital vaccination record is also suggestive of future connectivity to economic activity.
Efforts to link digital identity, not just to economic activity but also to health data, have recently escalated, for example with the piloting of Gavi, the Vaccine Alliance (aka GAVI)–Mastercard–Trust Stamp partnership in Africa.10
That program, first launched in 2018, links Trust Stamp’s digital-identity platform with the GAVI-Mastercard Wellness Pass, a digital vaccination record, and Mastercard’s click-to-pay system run on AI technology called NuData. Mastercard and GAVI are both partnered with the ID2020 Alliance, which includes VCI member Microsoft.
Given the reasonable speculation that such platforms would utilize digital currency, specifically cryptocurrency, for financial activity, it is worth noting that VCI member Microsoft filed a patent in 201911 that would allow “human body activity,” including brain waves and body heat, to mine (i.e., generate) cryptocurrency. This, of course, would link biometrics to financial activity, among other things.
Such a system, as laid out in the Microsoft patent, would likely require the introduction of wearables in order to be implemented. Notably, numerous wearables for contactless identity, digital travel passes and payment devices have recently been launched.
Examples include DigitalDNA,12 Proxy,13 and FlyWallet.14 FlyWallet is particularly notable as their latest product, Keyble,15 is a wearable that combines digital identity through fingerprint authentication, which enables both contactless payments and health applications such as vital-sign monitoring and data sharing with insurance companies and health care providers.
Sponsored by Spooks and Silicon Valley
The SMART Health Cards framework was developed by a team led by the chief architect of Microsoft Healthcare, Josh Mandel, who was previously16 the Health IT Ecosystem lead for Verily, formerly Google Life Sciences.
Verily is currently heavily involved in COVID-19 testing17 throughout the U.S., particularly in California, and links test recipients’ results to their Google accounts.18 Their other COVID-19 initiatives have been criticized due to still-unresolved privacy concerns,19 something that has also plagued several of Verily’s other efforts20 pre-COVID-19, including those involving Mandel.
Of particular concern is that Verily, and by extension Google, created Project Baseline, which has been collecting21 “actionable genetic information” with a focus on “population health” from participants since 2017. Yet, during the COVID-19 process, Project Baseline has become an important component22 of Verily’s COVID-19 testing efforts, raising the unsettling possibility that Verily has been obtaining Americans’ DNA data through its COVID-19 testing activities.
While Verily has not addressed this possibility directly, it is worth noting that Google has been heavily involved in amassing genomic data for several years. For instance, in 2013, Google Genomics was founded23 with the goal of storing and analyzing DNA data on Google Cloud servers.
Now known as Cloud Life Sciences, the Google subsidiary has since developed AI algorithms24 that can “build your genome sequence” and “identify all the mutations that an individual inherits from their parents.” Google also has close ties with the best-known DNA testing companies in the U.S., such as Ancestry.com.
Ancestry, recently purchased by private-equity behemoth Blackstone, shares data with a secretive Google subsidiary25 that uses genomic data to develop lifespan-extending therapies. In addition, the wife of Google cofounder Sergey Brin, Anne Wojcicki, is the cofounder and CEO of DNA testing company 23andMe. Wojcicki is also the sister of the CEO of Google-owned YouTube, Susan Wojcicki.
Google and the majority of VCI’s backers — Microsoft, Salesforce, Cerner, Epic, the Mayo Clinic, and MITRE Corporation, Change Healthcare — are also prominent members of the MITRE-run COVID-19 Healthcare Coalition.26
Other members of that coalition include the CIA’s In-Q-Tel and the CIA-linked data-mining firm Palantir,27 as well as a myriad of health care and health-record companies. The coalition fits well with the ambitions of Google and like-minded companies that have sought to gain access to troves of American health data under the guise of combating COVID-19.
The COVID-19 Healthcare Coalition describes itself28 as a public-private partnership that has enabled “the critical infrastructure to enable collaboration and shared analytics” on COVID-19 through the sharing of health-care and COVID-19 data among members.
That this coalition and VCI are intimately involved with MITRE Corporation is significant, given that MITRE is a well-known, yet secretive, contractor for the U.S. government, specifically the CIA and other intelligence agencies, which has developed29 Orwellian surveillance and biometric technologies, including several now focused on COVID-19.
Just three days before the public announcement of VCI’s establishment, Microsoft Healthcare and Google’s Verily announced a partnership30 along with MIT and Harvard’s Broad Institute to share the companies’ cloud data and AI technologies with a “global network of more than 168,000 health and life sciences partners” to accelerate the Terra platform.31
Terra, originally developed by the Broad Institute and Verily, is an “open data ecosystem” focused on biomedical research, specifically the fields of cancer genomics, population genetics and viral genomics. The biomedical data32 Terra amasses includes not only genetic data but also medical-imaging, biometric signals and electronic health records.
Google, through its partnership with the Pentagon, which was announced last September, has moved to utilize the analysis of such data in order to “predictively diagnose”33 diseases such as cancer and COVID-19. U.S. military contractors, such as Advanced Technology International,34 have been developing wearables that would apply that AI-driven predictive diagnosis technology to COVID-19 diagnoses.
Predictive COVID-19 diagnosis is also an ambition of another company that backs VCI, Salesforce. Salesforce is one of three companies that created COVID 360,35 which Salesforce senior vice president Bob Vanstraelen describes as36 a “free full Coronavirus treatment solution for patients and citizens at risk” that is hosted on Salesforce Health Cloud and was by Deloitte’s Israel branch and the Israeli intelligence-linked AI firm Diagnostic Robotics.37
COVID 360 uses the Diagnostic Robotics clinical-predictions platform and applies it to COVID-19 so that “government agencies or caretakers” can identify individuals “in proximity to a potential positive coronavirus case” and mandate coronavirus testing and/or treatment regimes, based on a risk profile generated by COVID 360. Diagnostic Robotics and Salesforce are both members of the MITRE-run COVID-19 Healthcare Coalition.
Salesforce founder, chair, and CEO Marc Benioff was previously a vice president at Oracle. Oracle, another VCI backer, was created as a spin-off of a CIA project38 of the same name, and its top executives have close ties to the outgoing Trump administration and also to Israel’s government. While Benioff’s pre-Salesforce history to a CIA-linked company like Oracle is significant, Benioff’s close ties to the World Economic Forum39 also deserve greater scrutiny.
Benioff is not only a member of the WEF’s board of trustees, but he is also the inaugural chair of the forum’s Centre for the Fourth Industrial Revolution, a “revolution” that its architect and WEF founder Klaus Schwab defines40 as a merging of humans’ physical, digital and biological identities. Benioff is also the owner and co-chair41 of Time magazine, which recently ran an entire issue42 focused on promoting the Fourth Industrial Revolution and the WEF-backed Great Reset.
Benioff also serves on the Council for Inclusive Capitalism,43 a collaboration between the Vatican and oligarchs to create a “more inclusive, sustainable and trusted economic system” for the 21st century.
Alongside Benioff on the council are well-known figures such as Lynn Forester de Rothschild (close associate of Jeffrey Epstein and the Clintons44), Mark Carney (UN special envoy for Climate Action and former governor of the Bank of England), and William Lauder (executive chairman of Estée Lauder, nephew of Mega Group45 member Ronald Lauder) as well as the top executives of MasterCard, Visa, Dupont, Merck, Johnson & Johnson, BP and Bank of America. Also present are the heads of the Ford and Rockefeller Foundations.
Benioff and others mentioned in this article are perfect examples of the cross-pollination between groups of oligarchs and their associated foundations and organizations and how these networks are working together to pursue a common agenda.
While the push for combining digital identity with vaccination records and economic activity appears, superficially, to be the effort of various organizations and groups, the same individuals and entities appear time and again, pointing to a coordinated push to not only implement such a system but manufacture consent for such a system among the global population.
The effort to manufacture consent for an all-encompassing digital identification system is notable given that its main selling point thus far has been coercion. We have been told that without such a system we will never be able to return to work or school, never be able to travel or never be allowed to participate normally in the economy.
While this system is being introduced in this way, it is essential to point out that coercion is a built-in part of this infrastructure and, if implemented, will be used to modify human behavior to great effect, reaching far beyond just the issue of COVID-19 vaccines.
(Natural News) In 2019 alone, President Donald Trump stripped Planned Parenthood of $60 million in taxpayer funding. The Biden regime is planning to undo this, however, by funneling tens of millions of new taxpayer dollars back into the baby butcher industry. In an announcement, Alexis McGill Johnson, president of the Planned Parenthood Action Fund, expressed…
(Natural News) After refusing to release data to the general public that some say could have helped to stem the tide of Wuhan coronavirus (COVID-19) “cases,” San Diego County was caught secretly sharing the home addresses and other private information of said “cases” with local law enforcement. For the past nine months, reports indicate, public…
(Natural News) The former aide of then-Senator Joe Biden has come forward to accuse the 46th “president” of being a sexual predator. Tara Reade says it was especially painful to have to watch Biden be “inaugurated” knowing that the sniffer-in-chief has never been held accountable for allegedly kissing her by force and “digitally penetrating her…
(Natural News) Technology giant Amazon has offered to help President Joe Biden with distributing the Wuhan coronavirus vaccine. In a letter to the president, an Amazon executive said the e-commerce giant “stands ready to assist” the Biden administration. The letter came amid the president’s announcement that 100 million Americans will be vaccinated against COVID-19 during…